Literature DB >> 28324021

Endogenous Calcitonin Gene-Related Peptide Regulates Lipid Metabolism and Energy Homeostasis in Male Mice.

Tian Liu1, Akiko Kamiyoshi1, Takayuki Sakurai1, Yuka Ichikawa-Shindo1, Hisaka Kawate1, Lei Yang1, Megumu Tanaka1, Xian Xian1, Akira Imai1, Liuyu Zhai1, Kazutaka Hirabayashi1, Kun Dai1, Keiya Tanimura1, Teng Liu1, Nanqi Cui1, Kyoko Igarashi2, Akihiro Yamauchi2, Takayuki Shindo1.   

Abstract

Calcitonin gene-related peptide (CGRP) is a bioactive peptide produced by alternative splicing of the primary transcript of the calcitonin/CGRP gene. CGRP is largely distributed in the cardiovascular and nervous systems, where it acts as a regulatory factor. CGRP is also expressed in organs and tissues involved in metabolic regulation, including white adipose tissue (WAT), where its function is largely unknown. In this study, we examined the effects of endogenous CGRP on metabolic function. When we administered a high-fat diet to CGRP-specific knockout (CGRP-/-) and wild-type (WT) mice for 10 weeks, we observed that food intake did not differ between the two groups, but body weight and visceral fat weight were significantly lower in CGRP-/- mice. Fatty liver changes were less severe in CGRP-/- mice, which also showed lower serum insulin and leptin levels. Glucose tolerance and insulin sensitivity were better in CGRP-/- than WT mice, and expired gas analysis revealed greater oxygen consumption by CGRP-/- mice. Adipocyte hypertrophy was suppressed in CGRP-/- mice, while expression of β-3-adrenergic receptor, hormone-sensitive lipase and adiponectin was enhanced. Isoproterenol-induced glycerol release from WAT was higher in CGRP-/- than WT mice, and CGRP-/- mice showed elevated sympathetic nervous activity. β-receptor-blockade canceled the beneficial effects of CGRP deletion on obesity. These results suggest that, in addition to its actions in the cardiovascular system, endogenous CGRP is a key regulator of metabolism and energy homeostasis in vivo.
Copyright © 2017 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28324021     DOI: 10.1210/en.2016-1510

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

Review 1.  Molecular pathways linking adipose innervation to insulin action in obesity and diabetes mellitus.

Authors:  Adilson Guilherme; Felipe Henriques; Alexander H Bedard; Michael P Czech
Journal:  Nat Rev Endocrinol       Date:  2019-04       Impact factor: 43.330

2.  Serum calcitonin gene-related peptide facilitates adipose tissue lipolysis during exercise via PIPLC/IP3 pathways.

Authors:  Malihe Aveseh; Maryam Koushkie-Jahromi; Javad Nemati; Saeed Esmaeili-Mahani
Journal:  Endocrine       Date:  2018-06-13       Impact factor: 3.633

3.  Bariatric Surgery in Migraine patients: CGRP Level and Weight Loss.

Authors:  Helia Hemasian Etefagh; Shahab Shahabi Shahmiri; Hamid Melali; Masoud Sayadi; Hossein Ansari; Arvin Shahzamani; Mitra Sadat Deyhimi
Journal:  Obes Surg       Date:  2022-08-03       Impact factor: 3.479

Review 4.  Role of calcitonin gene-related peptide in energy metabolism.

Authors:  William Gustavo Lima; Gleuber Henrique Marques-Oliveira; Thaís Marques da Silva; Valéria Ernestânia Chaves
Journal:  Endocrine       Date:  2017-09-07       Impact factor: 3.633

5.  Differential effects of Calca-derived peptides in male mice with diet-induced obesity.

Authors:  Alexander Bartelt; Anke Jeschke; Brigitte Müller; Isabella Gaziano; Michelle Morales; Timur Yorgan; Timo Heckt; Markus Heine; Robert F Gagel; Ronald B Emeson; Michael Amling; Andreas Niemeier; Jörg Heeren; Thorsten Schinke; Johannes Keller
Journal:  PLoS One       Date:  2017-06-30       Impact factor: 3.240

6.  α-Calcitonin gene-related peptide inhibits autophagy and calpain systems and maintains the stability of neuromuscular junction in denervated muscles.

Authors:  Juliano Machado; Wilian A Silveira; Dawit A Gonçalves; Aline Zanatta Schavinski; Muzamil M Khan; Neusa M Zanon; Mauricio Berriel Diaz; Rüdiger Rudolf; Isis C Kettelhut; Luiz C Navegantes
Journal:  Mol Metab       Date:  2019-07-03       Impact factor: 7.422

Review 7.  Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases.

Authors:  Nina Sonne; Morten A Karsdal; Kim Henriksen
Journal:  Mol Metab       Date:  2020-11-07       Impact factor: 7.422

8.  Lipidated Calcitonin Gene-Related Peptide (CGRP) Peptide Antagonists Retain CGRP Receptor Activity and Attenuate CGRP Action In Vivo.

Authors:  Aqfan Jamaluddin; Chia-Lin Chuang; Elyse T Williams; Andrew Siow; Sung Hyun Yang; Paul W R Harris; Jakeb S S M Petersen; Rebekah L Bower; Shanan Chand; Margaret A Brimble; Christopher S Walker; Debbie L Hay; Kerry M Loomes
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

9.  Calcitonin-Receptor-Like Receptor Signaling Governs Intestinal Lymphatic Innervation and Lipid Uptake.

Authors:  Reema B Davis; Shengli Ding; Natalie R Nielsen; John B Pawlak; Elizabeth S Blakeney; Kathleen M Caron
Journal:  ACS Pharmacol Transl Sci       Date:  2019-01-29

10.  Endogenous calcitonin regulates lipid and glucose metabolism in diet-induced obesity mice.

Authors:  Misa Nakamura; Sachiko Nomura; Tadashi Yamakawa; Ryohei Kono; Akihiro Maeno; Takashi Ozaki; Akitoshi Ito; Toyonobu Uzawa; Hirotoshi Utsunomiya; Kennichi Kakudo
Journal:  Sci Rep       Date:  2018-11-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.